The cluster's extreme buying imbalance (13:3 buyers vs sellers) strongly outweighs the negative signal from three insider sells totaling ~$1M. Given the 45-day 13F lag, these Q3 positions may have already been adjusted, monitor for subsequent share-price catalyst events (pipeline readouts, capital raises). The active-manager-dominated buying (Janus, Pictet, Walleye) carries more signal than the passive additions. If the current price is still near Q3 levels, the cluster suggests deep undervaluation; if it has rallied significantly, the edge is partially consumed.
SYRE drugs
SYRE drug pipeline →How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 12 $80.79entry
- T+1 · 5mo ago +3.45%α +1.69% · $83.58
- T+5 · 5mo ago +9.35%α +8.67% · $88.34
- T+20 · 4mo ago +20.98%α +19.20% · $97.74
- T+60 · 2mo ago +12.38%α +9.11% · $90.79
How similar events traded
Executive Summary
A major institutional cluster reveals 13 net buyers vs 3 net sellers in SYRE during Q3 2024, with aggregate buying of $81.0M (net +$48.6M) strongly outweighing selling of $25.6M. Notable active managers including Janus Henderson and Pictet doubled or added significant positions, while Farallon and Avoro fully exited or trimmed. This signals a powerful collective conviction that Spyre's pipeline (likely the IMGS-100 series) is undervalued, despite the 45-day 13F reporting lag.
Key Financial Metrics
Institutional Positions
Net institutional flow: $48.6M
▲ Buyers (13)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Janus Henderson Group | ADD | +66.3% | $32.9M | $17.0M |
| Pictet Asset Management | DOUBLED | +113.6% | $24.3M | $15.2M |
| Walleye Capital | ADD | +61.4% | $7.2M | $3.6M |
| Schwab | DOUBLED | +239.4% | $9.8M | $7.5M |
| Invesco | DOUBLED | +742.4% | $4.1M | $3.7M |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Farallon Capital Management | EXIT | -100% | $15.7M | -$15.7M |
| Avoro Capital Advisors | TRIM | -67.5% | $43.2M | -$25.6M |
| Voloridge Investment Management | TRIM | -43.1% | $6.5M | -$1.9M |
Key Facts
- 13 net buyers vs 3 net sellers in Q3 2024
- Aggregate buy-side value: $81.0M (net change +$48.6M)
- Top buyer by scale: Janus Henderson added $17.0M (adds of 66.3%)
- Pictet more than doubled its stake (+113.6%), adding $15.2M
- Two major sellers completely exited or deeply trimmed: Farallon EXIT (-$15.7M), Avoro TRIM (-$25.6M)
- Three mega-passive funds (Schwab, Invesco, T. Rowe) uniformly added, confirming no forced index selling
Financial Impact
13 institutions accumulated $81.0M in SYRE (net inflow +$48.6M) while 3 sellers shed $25.6M, overwhelming buying pressure
Risk Factors
- 13F data is 45+ days stale; positions may have been partially or fully unwound by now
- 13F filings omit short positions and options exposure, the cluster signal is one-sided
- Three insider sells totaling ~$1M in the past 30 days may temper the bullish read
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-SYRE-2024-Q3 |
Track record
36 reports on SYRE
7 of 11 bullish or bearish reports moved the stock their way by T+60. Best: +54.27% at T+60 after the Apr 13, 2026 report. 14 of 20 went positive at some point.
Filters
- Nov 3, 202613d ago 8-K Neutral 5/10 No price data
- Nov 3, 202613d ago Press Release Bearish 5/10 Entry $99.04 settles Feb 2
- Oct 12, 20265w ago Institutional Cluster Bullish 4/10 Entry $85.90 settles Jan 7
- Oct 9, 20265w ago SC 13D/A Neutral 3/10 Entry $85.90 settles Jan 7
- Oct 7, 20265w ago 8-K Bearish 5/10 Entry $80.85 settles Jan 4
- Oct 6, 20265w ago 424B5 Bearish 6/10 Entry $80.85 settles Jan 4
- Oct 5, 20266w ago Press Release Bearish 6/10 Entry $80.11 settles Dec 31
- Oct 5, 20266w ago 424B5 Bearish 5/10 Entry $80.11 settles Dec 31
- Oct 5, 20266w ago Press Release Bearish 5/10 Entry $80.11 settles Dec 31
- Oct 2, 20266w ago Insider Cluster Bearish 4/10 Entry $92.72 settles Dec 30
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers